nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Parkinson's disease	0.709	1	CbGaD
Vecuronium—CHRND—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Parkinson's disease	0.0128	0.0534	CbGpPWpGaD
Vecuronium—CHRNA1—tongue—Parkinson's disease	0.00964	0.186	CbGeAlD
Vecuronium—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.00889	0.0371	CbGpPWpGaD
Vecuronium—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.00844	0.0353	CbGpPWpGaD
Vecuronium—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0083	0.0347	CbGpPWpGaD
Vecuronium—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.00757	0.0316	CbGpPWpGaD
Vecuronium—CHRND—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.00734	0.0307	CbGpPWpGaD
Vecuronium—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.00719	0.03	CbGpPWpGaD
Vecuronium—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.00706	0.0295	CbGpPWpGaD
Vecuronium—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.00671	0.028	CbGpPWpGaD
Vecuronium—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.00624	0.0261	CbGpPWpGaD
Vecuronium—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.00593	0.0248	CbGpPWpGaD
Vecuronium—CHRND—cardiovascular system—Parkinson's disease	0.00414	0.0797	CbGeAlD
Vecuronium—SLC22A1—Abacavir transmembrane transport—ABCB1—Parkinson's disease	0.00412	0.0172	CbGpPWpGaD
Vecuronium—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.00353	0.0147	CbGpPWpGaD
Vecuronium—CHRNA2—forebrain—Parkinson's disease	0.00339	0.0653	CbGeAlD
Vecuronium—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.003	0.0125	CbGpPWpGaD
Vecuronium—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.00298	0.0125	CbGpPWpGaD
Vecuronium—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—SLC18A2—Parkinson's disease	0.00281	0.0118	CbGpPWpGaD
Vecuronium—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.0027	0.0113	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00264	0.011	CbGpPWpGaD
Vecuronium—SLC22A1—Abacavir transport and metabolism—ABCB1—Parkinson's disease	0.00237	0.00988	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—HCN3—Parkinson's disease	0.00236	0.00987	CbGpPWpGaD
Vecuronium—CHRNA1—head—Parkinson's disease	0.00234	0.0451	CbGeAlD
Vecuronium—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00232	0.0097	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00228	0.00953	CbGpPWpGaD
Vecuronium—CHRNB1—medulla oblongata—Parkinson's disease	0.00228	0.0439	CbGeAlD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00225	0.00939	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00213	0.00892	CbGpPWpGaD
Vecuronium—CHRNB1—midbrain—Parkinson's disease	0.00208	0.0401	CbGeAlD
Vecuronium—CHRNB1—spinal cord—Parkinson's disease	0.00203	0.0391	CbGeAlD
Vecuronium—CHRNA1—Neuronal System—HCN3—Parkinson's disease	0.00201	0.00839	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00199	0.0083	CbGpPWpGaD
Vecuronium—SLC22A1—forebrain—Parkinson's disease	0.00199	0.0382	CbGeAlD
Vecuronium—CHRNA2—head—Parkinson's disease	0.00194	0.0374	CbGeAlD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00194	0.0081	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—HCN3—Parkinson's disease	0.00191	0.00797	CbGpPWpGaD
Vecuronium—SLC22A1—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.00187	0.00781	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00184	0.0077	CbGpPWpGaD
Vecuronium—CHRNA2—nervous system—Parkinson's disease	0.00184	0.0354	CbGeAlD
Vecuronium—CHRNB1—head—Parkinson's disease	0.00181	0.0348	CbGeAlD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00179	0.00746	CbGpPWpGaD
Vecuronium—CHRNA2—central nervous system—Parkinson's disease	0.00177	0.0341	CbGeAlD
Vecuronium—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Parkinson's disease	0.00177	0.00738	CbGpPWpGaD
Vecuronium—CHRNA2—cerebellum—Parkinson's disease	0.00173	0.0334	CbGeAlD
Vecuronium—CHRND—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00172	0.00716	CbGpPWpGaD
Vecuronium—CHRNA1—brain—Parkinson's disease	0.0017	0.0327	CbGeAlD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00169	0.00706	CbGpPWpGaD
Vecuronium—CHRNB1—cerebellum—Parkinson's disease	0.00161	0.031	CbGeAlD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.0016	0.0067	CbGpPWpGaD
Vecuronium—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—Parkinson's disease	0.00156	0.00651	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—KCNJ4—Parkinson's disease	0.00152	0.00636	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00152	0.00634	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00152	0.00634	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00146	0.00609	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00144	0.00602	CbGpPWpGaD
Vecuronium—SLC22A1—Neurotransmitter Release Cycle—SLC18A2—Parkinson's disease	0.00143	0.00597	CbGpPWpGaD
Vecuronium—CHRNA2—brain—Parkinson's disease	0.00141	0.0271	CbGeAlD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00139	0.00579	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00134	0.0056	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—DLG1—Parkinson's disease	0.00131	0.00549	CbGpPWpGaD
Vecuronium—CHRNB1—brain—Parkinson's disease	0.00131	0.0252	CbGeAlD
Vecuronium—CHRNA1—Neuronal System—KCNJ4—Parkinson's disease	0.00129	0.00541	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00129	0.00539	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—KCNJ4—Parkinson's disease	0.00123	0.00514	CbGpPWpGaD
Vecuronium—SLC22A1—Amine compound SLC transporters—SLC6A3—Parkinson's disease	0.00123	0.00512	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00123	0.00512	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00116	0.00486	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00114	0.00477	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00114	0.00477	CbGpPWpGaD
Vecuronium—SLC22A1—head—Parkinson's disease	0.00114	0.0219	CbGeAlD
Vecuronium—CHRNA1—Neuronal System—DLG1—Parkinson's disease	0.00112	0.00467	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00111	0.00462	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00108	0.00453	CbGpPWpGaD
Vecuronium—SLC22A1—nervous system—Parkinson's disease	0.00108	0.0208	CbGeAlD
Vecuronium—CHRNA2—Neuronal System—DLG1—Parkinson's disease	0.00106	0.00443	CbGpPWpGaD
Vecuronium—SLC22A1—central nervous system—Parkinson's disease	0.00104	0.02	CbGeAlD
Vecuronium—SLC22A1—Neurotransmitter Release Cycle—HSPA8—Parkinson's disease	0.00104	0.00433	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—GRIK1—Parkinson's disease	0.00103	0.00429	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.001	0.00418	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000989	0.00413	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000978	0.00409	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00097	0.00405	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00094	0.00392	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00094	0.00392	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000922	0.00385	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000893	0.00373	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—HCN3—Parkinson's disease	0.000877	0.00366	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000875	0.00365	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—GRIK1—Parkinson's disease	0.000874	0.00365	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—GRIK2—Parkinson's disease	0.000874	0.00365	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000851	0.00355	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—SLC18A2—Parkinson's disease	0.000847	0.00354	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000832	0.00347	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—GRIK1—Parkinson's disease	0.000831	0.00347	CbGpPWpGaD
Vecuronium—SLC22A1—brain—Parkinson's disease	0.000824	0.0159	CbGeAlD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—MAPK8—Parkinson's disease	0.000819	0.00342	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000808	0.00338	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000802	0.00335	CbGpPWpGaD
Vecuronium—SLC22A1—Neurotransmitter Release Cycle—MAOA—Parkinson's disease	0.000791	0.0033	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00079	0.0033	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000752	0.00314	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000744	0.00311	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—GRIK2—Parkinson's disease	0.000743	0.0031	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000737	0.00308	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000735	0.00307	CbGpPWpGaD
Vecuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000732	0.00306	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000725	0.00303	CbGpPWpGaD
Vecuronium—ABCB1—embryo—Parkinson's disease	0.000724	0.014	CbGeAlD
Vecuronium—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000722	0.00301	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—SLC18A2—Parkinson's disease	0.00072	0.00301	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000706	0.00295	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—GRIK2—Parkinson's disease	0.000706	0.00295	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—SLC18A2—Parkinson's disease	0.000684	0.00286	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000682	0.00285	CbGpPWpGaD
Vecuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000673	0.00281	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—CHRNA4—Parkinson's disease	0.00067	0.0028	CbGpPWpGaD
Vecuronium—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000667	0.00279	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000648	0.0027	CbGpPWpGaD
Vecuronium—ABCB1—forebrain—Parkinson's disease	0.000641	0.0123	CbGeAlD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00064	0.00267	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000636	0.00266	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000625	0.00261	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000616	0.00257	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000616	0.00257	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—HSPA8—Parkinson's disease	0.000614	0.00257	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000614	0.00256	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000612	0.00256	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000608	0.00254	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000594	0.00248	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000585	0.00244	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000577	0.00241	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—DLG4—Parkinson's disease	0.000576	0.00241	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—CHRNA4—Parkinson's disease	0.00057	0.00238	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—KCNJ4—Parkinson's disease	0.000565	0.00236	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—GRIN2B—Parkinson's disease	0.000563	0.00235	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—SLC6A3—Parkinson's disease	0.000555	0.00232	CbGpPWpGaD
Vecuronium—ABCB1—cardiovascular system—Parkinson's disease	0.000542	0.0104	CbGeAlD
Vecuronium—CHRNA2—Neuronal System—CHRNA4—Parkinson's disease	0.000541	0.00226	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000537	0.00224	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000524	0.00219	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—HSPA8—Parkinson's disease	0.000522	0.00218	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00052	0.00217	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000511	0.00213	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000498	0.00208	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000498	0.00208	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—HSPA8—Parkinson's disease	0.000496	0.00207	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000494	0.00206	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—DLG4—Parkinson's disease	0.00049	0.00205	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—DLG1—Parkinson's disease	0.000488	0.00204	CbGpPWpGaD
Vecuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00048	0.002	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—GRIN2B—Parkinson's disease	0.000479	0.002	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—SLC6A3—Parkinson's disease	0.000472	0.00197	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—COMT—Parkinson's disease	0.000472	0.00197	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—MAOA—Parkinson's disease	0.000469	0.00196	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—DLG4—Parkinson's disease	0.000466	0.00194	CbGpPWpGaD
Vecuronium—ABCB1—medulla oblongata—Parkinson's disease	0.000463	0.00891	CbGeAlD
Vecuronium—CHRNA2—Neuronal System—GRIN2B—Parkinson's disease	0.000455	0.0019	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—SLC6A3—Parkinson's disease	0.000449	0.00187	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000423	0.00177	CbGpPWpGaD
Vecuronium—ABCB1—midbrain—Parkinson's disease	0.000423	0.00815	CbGeAlD
Vecuronium—ABCB1—spinal cord—Parkinson's disease	0.000413	0.00795	CbGeAlD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00041	0.00171	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000402	0.00168	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—COMT—Parkinson's disease	0.000401	0.00168	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—MAOA—Parkinson's disease	0.000399	0.00166	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—GRIK1—Parkinson's disease	0.000382	0.00159	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—COMT—Parkinson's disease	0.000381	0.00159	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—MAOA—Parkinson's disease	0.000379	0.00158	CbGpPWpGaD
Vecuronium—ABCB1—head—Parkinson's disease	0.000367	0.00706	CbGeAlD
Vecuronium—ABCB1—nervous system—Parkinson's disease	0.000348	0.0067	CbGeAlD
Vecuronium—ABCB1—central nervous system—Parkinson's disease	0.000335	0.00645	CbGeAlD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000332	0.00139	CbGpPWpGaD
Vecuronium—ABCB1—cerebellum—Parkinson's disease	0.000327	0.0063	CbGeAlD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000325	0.00136	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—GRIK2—Parkinson's disease	0.000324	0.00135	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000319	0.00133	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000318	0.00133	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000318	0.00133	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—SLC18A2—Parkinson's disease	0.000314	0.00131	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000306	0.00128	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000301	0.00126	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000298	0.00124	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000279	0.00117	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000273	0.00114	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00027	0.00113	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000269	0.00112	CbGpPWpGaD
Vecuronium—ABCB1—brain—Parkinson's disease	0.000266	0.00512	CbGeAlD
Vecuronium—SLC22A1—Neuronal System—CHRNA4—Parkinson's disease	0.000249	0.00104	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.00024	0.001	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000229	0.000955	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—HSPA8—Parkinson's disease	0.000228	0.000952	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000227	0.000948	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000224	0.000936	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000218	0.00091	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—DLG4—Parkinson's disease	0.000214	0.000893	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—GRIN2B—Parkinson's disease	0.000209	0.000873	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—SLC6A3—Parkinson's disease	0.000206	0.00086	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000187	0.000779	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000187	0.000779	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—COMT—Parkinson's disease	0.000175	0.000732	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MAOA—Parkinson's disease	0.000174	0.000727	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000169	0.000706	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ND3—Parkinson's disease	0.000167	0.000699	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MCCC1—Parkinson's disease	0.000167	0.000699	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TALDO1—Parkinson's disease	0.000157	0.000657	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—OMD—Parkinson's disease	0.000157	0.000657	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000155	0.000649	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NDUFB11—Parkinson's disease	0.000149	0.000623	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GCH1—Parkinson's disease	0.000142	0.000594	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000135	0.000565	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000135	0.000565	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000135	0.000563	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000133	0.000556	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—DBH—Parkinson's disease	0.000127	0.000529	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—FBP1—Parkinson's disease	0.000127	0.000529	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GBA—Parkinson's disease	0.000127	0.000529	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000118	0.000494	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000111	0.000463	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000106	0.000444	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.9e-05	0.000414	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TNF—Parkinson's disease	9.81e-05	0.00041	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ND3—Parkinson's disease	9.81e-05	0.00041	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MCCC1—Parkinson's disease	9.81e-05	0.00041	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—DDC—Parkinson's disease	9.31e-05	0.000389	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.25e-05	0.000386	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—OMD—Parkinson's disease	9.22e-05	0.000385	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TALDO1—Parkinson's disease	9.22e-05	0.000385	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.11e-05	0.000381	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.87e-05	0.000371	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA4—Parkinson's disease	8.79e-05	0.000367	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NDUFB11—Parkinson's disease	8.74e-05	0.000365	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GCH1—Parkinson's disease	8.34e-05	0.000348	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	7.91e-05	0.00033	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MAOB—Parkinson's disease	7.83e-05	0.000327	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GBA—Parkinson's disease	7.43e-05	0.00031	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—DBH—Parkinson's disease	7.43e-05	0.00031	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—FBP1—Parkinson's disease	7.43e-05	0.00031	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	6.66e-05	0.000278	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.49e-05	0.000271	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.23e-05	0.00026	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	6.12e-05	0.000255	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	5.82e-05	0.000243	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CTGF—Parkinson's disease	5.71e-05	0.000239	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—DDC—Parkinson's disease	5.45e-05	0.000228	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.42e-05	0.000226	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	5.32e-05	0.000222	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NQO1—Parkinson's disease	5.26e-05	0.00022	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TH—Parkinson's disease	5.19e-05	0.000217	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.15e-05	0.000215	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYCS—Parkinson's disease	4.98e-05	0.000208	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.84e-05	0.000202	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.64e-05	0.000194	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MAOB—Parkinson's disease	4.59e-05	0.000192	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—COMT—Parkinson's disease	4.41e-05	0.000184	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTP1—Parkinson's disease	4.39e-05	0.000183	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MAOA—Parkinson's disease	4.38e-05	0.000183	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HMOX1—Parkinson's disease	4.33e-05	0.000181	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCB1—Parkinson's disease	4.16e-05	0.000174	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM1—Parkinson's disease	4.03e-05	0.000169	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPX1—Parkinson's disease	3.86e-05	0.000161	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTHFR—Parkinson's disease	3.57e-05	0.000149	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.41e-05	0.000142	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CTGF—Parkinson's disease	3.35e-05	0.00014	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—APOE—Parkinson's disease	3.32e-05	0.000139	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.12e-05	0.00013	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NQO1—Parkinson's disease	3.09e-05	0.000129	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TH—Parkinson's disease	3.04e-05	0.000127	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYCS—Parkinson's disease	2.92e-05	0.000122	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—INS—Parkinson's disease	2.84e-05	0.000118	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—COMT—Parkinson's disease	2.59e-05	0.000108	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.57e-05	0.000107	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MAOA—Parkinson's disease	2.57e-05	0.000107	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.54e-05	0.000106	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.36e-05	9.88e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPX1—Parkinson's disease	2.26e-05	9.46e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.09e-05	8.73e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—APOE—Parkinson's disease	1.95e-05	8.13e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—INS—Parkinson's disease	1.66e-05	6.94e-05	CbGpPWpGaD
